Exclusive: head of key research into third dose says it may be better to prioritise vulnerable first
There is “almost certainly no urgency” to press ahead with booster shots for healthy adults and it may be better to see how the pandemic pans out before deciding, the scientist leading key research into third shots has said.
Prof Saul Faust, chief investigator of the Cov-Boost study whose data next week is expected to help inform a decision on the rollout of boosters across the UK, told the Guardian that for now it may be preferable to prioritise only the vulnerable, including those with compromised immune systems.
